Marc Hedrick
Amministratore Delegato presso PLUS THERAPEUTICS, INC.
Patrimonio netto: 27 537 $ in data 31/05/2024
Profilo
Marc H.
Hedrick was the founder of StemSource, Inc. (founded in 2000) where he served as the President, Chief Executive Officer & Director from 2001 to 2003.
He is currently the President, Chief Executive Officer & Director at Plus Therapeutics, Inc. since 2002.
Dr. Hedrick has also held former positions as the President, Chief Executive Officer & Director at Cytori Therapeutics, Inc. (JP), Chief Scientific Officer & Medical Director at MacroPore Biosurgery, Inc. from 2002 to 2004, Co-Director at UCLA Anderson School of Management, Director at Cytori Ltd., and Associate Professor at the University of California, Los Angeles.
He holds a doctorate degree from The University of Texas Southwestern Medical Center (1988) and an MBA from UCLA Anderson School of Management (2005).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PLUS THERAPEUTICS, INC.
0.22% | 08/05/2024 | 12 425 ( 0.22% ) | 27 459 $ | 31/05/2024 |
| 25/07/2018 | 35 ( 3.73% ) | 77 $ | 31/05/2024 |
Posizioni attive di Marc Hedrick
| Società | Posizione | Inizio |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Amministratore Delegato | 02/04/2014 |
Precedenti posizioni note di Marc Hedrick
| Società | Posizione | Fine |
|---|---|---|
| MacroPore Biosurgery, Inc. /Old/ | Direttore Tecnico/Scientifico/R&S | 01/01/2004 |
StemSource, Inc.
 StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Plus Therapeutics, Inc., StemSource, Inc. develops treatments for cancer. The company is based in Thousand Oaks, CA. The company was founded by Adam J. Katz, Marc H. Hedrick. StemSource was acquired by MacroPore Biosurgery, Inc. on November 30, 2002 for $5.71 million. | Fondatore | 01/01/2003 |
| UCLA Anderson School of Management | Corporate Officer/Principal | - |
| University of California, Los Angeles | Corporate Officer/Principal | - |
Cytori Therapeutics, Inc. (JP)
 Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Cytori Therapeutics KK engages in the manufacture, import, export and sales of medical devices. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Amministratore Delegato | - |
Formazione di Marc Hedrick
| The University of Texas Southwestern Medical Center | Doctorate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PLUS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
| MacroPore Biosurgery, Inc. /Old/ | Health Technology |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Plus Therapeutics, Inc., StemSource, Inc. develops treatments for cancer. The company is based in Thousand Oaks, CA. The company was founded by Adam J. Katz, Marc H. Hedrick. StemSource was acquired by MacroPore Biosurgery, Inc. on November 30, 2002 for $5.71 million. | Commercial Services |
Cytori Ltd.
 Cytori Ltd. Pharmaceuticals: OtherHealth Technology Cytori Ltd. develops biological products. The company was founded on February 7, 2014 and is headquartered in Deeside, the United Kingdom. | Health Technology |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Cytori Therapeutics KK engages in the manufacture, import, export and sales of medical devices. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Marc Hedrick
